Why Isn’t This Front-Page News?

Leave a CommentWhy Isn’t This Front-Page News?Commentary

Four major data sets from the U.S., South Korea, and Italy show a clear and worrying rise in cancer after the COVID vaccine rollout. These findings point to a serious public health disaster that is hitting families hard right now.

Sharp Rise in Young Cancers in the U.S.

U.S. government SEER cancer records reveal that early-onset cancers—in people under age 50—jumped 6.4% between 2021 and 2023. That was exactly when the big push for mRNA shots happened. Rates climbed from 109 to 116 cases per 100,000 people. Brain and nervous system tumors rose 19.5%, colon and rectal cancer increased 19.4%, and there were big jumps in ovarian, stomach, and breast cancers too. CDC death records show more than 138,000 extra cancer deaths in the U.S. since 2021. The charts show a sudden upward turn starting in spring 2021.

Higher Cancer Risks in South Korea

A large South Korean study followed 8.4 million people. Those who received the COVID vaccines had clearly higher risks for several major cancers in just the first year. Lung cancer risk was 53% higher, prostate cancer 69% higher, and increases were also seen in thyroid, stomach, colorectal, and breast cancers. These are not small changes.

More Hospitalizations in Italy

In Italy, doctors tracked almost 300,000 people in one area for 30 months. People who got at least one vaccine dose had a 23% higher chance of being hospitalized for cancer. The risks were especially high for colorectal, breast, and bladder cancers.

What These Numbers Really Mean

These bad results line up across different countries and different types of data. They match the timing of the mass vaccination campaign. Doctors are seeing faster-growing, more aggressive cancers in younger people—sometimes called “turbo cancers.” Thousands of extra deaths and many more sick people are the result. This is not normal and it is hurting real families today.

Who Did This?

Who rushed these shots onto the market without enough long-term safety testing? Who keeps pushing them while this troubling data piles up? Regular people deserve honest answers instead of silence. The numbers are loud and clear—this looks like an unfolding disaster. 

Here are the four studies/datasets referenced in the post above:

  1. U.S. SEER Cancer Incidence Data
    National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. Shows a 6.4% rise in early-onset cancers (under age 50) from 2021 to 2023, with sharp increases in brain/nervous system tumors (+19.5%), colon/rectal cancer (+19.4%), and others. This lines up exactly with the peak mRNA vaccine rollout period.
  2. CDC WONDER Mortality Data
    U.S. Centers for Disease Control and Prevention’s Wide-ranging Online Data for Epidemiologic Research database. Reports more than 138,000 excess cancer deaths in the U.S. since 2021, with charts showing a clear upward shift starting in spring 2021.
  3. South Korean Population-Based Cohort Study
    “1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea” (Biomarker Research, 2025).
    Tracked 8.4 million people. Found higher 1-year risks for six major cancers after vaccination: lung (HR 1.53), prostate (HR 1.69), thyroid (HR 1.35), gastric (HR 1.34), colorectal (HR 1.28), and breast (HR 1.20).
  4. Italian 30-Month Cohort Study
    “COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province” (EXCLI Journal, 2025).
    Followed 296,015 residents in Pescara province. People who received at least one dose had a 23% higher risk of cancer hospitalization (HR 1.23), with elevated risks for colorectal (HR 1.35), breast (HR 1.54), and bladder (HR 1.62) cancers.

These four independent sources—from U.S. government records and large real-world studies in two other countries—all point to the same troubling pattern after the COVID vaccine program began.